Annual FCF
$73.09 M
-$144.29 M-66.38%
December 31, 2023
Summary
- As of February 25, 2025, IART annual free cash flow is $73.09 million, with the most recent change of -$144.29 million (-66.38%) on December 31, 2023.
- During the last 3 years, IART annual FCF has fallen by -$66.85 million (-47.77%).
- IART annual FCF is now -72.35% below its all-time high of $264.35 million, reached on December 31, 2021.
Performance
IART Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$7.16 M
-$17.86 M-166.96%
September 30, 2024
Summary
- As of February 25, 2025, IART quarterly free cash flow is -$7.16 million, with the most recent change of -$17.86 million (-166.96%) on September 30, 2024.
- Over the past year, IART quarterly FCF has dropped by -$20.85 million (-152.30%).
- IART quarterly FCF is now -108.46% below its all-time high of $84.66 million, reached on June 30, 2021.
Performance
IART Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$38.04 M
-$20.85 M-35.41%
September 30, 2024
Summary
- As of February 25, 2025, IART TTM free cash flow is $38.04 million, with the most recent change of -$20.85 million (-35.41%) on September 30, 2024.
- Over the past year, IART TTM FCF has dropped by -$71.71 million (-65.34%).
- IART TTM FCF is now -86.14% below its all-time high of $274.39 million, reached on September 30, 2021.
Performance
IART TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IART Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.4% | -152.3% | -65.3% |
| 3 y3 years | -47.8% | -152.3% | -65.3% |
| 5 y5 years | -40.1% | -152.3% | -65.3% |
IART Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.3% | at low | -110.1% | at low | -85.6% | at low |
| 5 y | 5-year | -72.3% | at low | -108.5% | at low | -86.1% | at low |
| alltime | all time | -72.3% | +765.7% | -108.5% | +74.5% | -86.1% | +209.2% |
Integra LifeSciences Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.16 M(-167.0%) | $38.04 M(-35.4%) |
| Jun 2024 | - | $10.69 M(+3574.9%) | $58.89 M(-3.3%) |
| Mar 2024 | - | $291.00 K(-99.1%) | $60.93 M(-16.6%) |
| Dec 2023 | $73.09 M(-66.4%) | $34.22 M(+149.9%) | $73.09 M(-33.4%) |
| Sep 2023 | - | $13.69 M(+7.5%) | $109.75 M(-29.3%) |
| Jun 2023 | - | $12.73 M(+2.2%) | $155.22 M(-22.2%) |
| Mar 2023 | - | $12.45 M(-82.4%) | $199.56 M(-8.2%) |
| Dec 2022 | $217.38 M(-17.8%) | $70.88 M(+19.8%) | $217.38 M(+15.4%) |
| Sep 2022 | - | $59.16 M(+3.7%) | $188.30 M(-8.0%) |
| Jun 2022 | - | $57.07 M(+88.5%) | $204.63 M(-11.9%) |
| Mar 2022 | - | $30.28 M(-27.6%) | $232.22 M(-12.2%) |
| Dec 2021 | $264.35 M(+88.9%) | $41.79 M(-44.6%) | $264.35 M(-3.7%) |
| Sep 2021 | - | $75.49 M(-10.8%) | $274.39 M(+4.8%) |
| Jun 2021 | - | $84.66 M(+35.7%) | $261.81 M(+28.9%) |
| Mar 2021 | - | $62.41 M(+20.4%) | $203.05 M(+45.1%) |
| Dec 2020 | $139.94 M(+44.4%) | $51.84 M(-17.6%) | $139.94 M(-9.8%) |
| Sep 2020 | - | $62.91 M(+142.9%) | $155.10 M(+99.3%) |
| Jun 2020 | - | $25.90 M(-3773.8%) | $77.84 M(-6.0%) |
| Mar 2020 | - | -$705.00 K(-101.1%) | $82.80 M(-14.6%) |
| Dec 2019 | $96.90 M(-20.5%) | $66.99 M(-566.9%) | $96.90 M(+106.6%) |
| Sep 2019 | - | -$14.35 M(-146.5%) | $46.91 M(-62.1%) |
| Jun 2019 | - | $30.86 M(+130.3%) | $123.84 M(+13.4%) |
| Mar 2019 | - | $13.40 M(-21.2%) | $109.20 M(-10.5%) |
| Dec 2018 | $121.94 M(+71.7%) | $17.00 M(-72.8%) | $121.94 M(+18.6%) |
| Sep 2018 | - | $62.58 M(+286.0%) | $102.79 M(+32.4%) |
| Jun 2018 | - | $16.21 M(-38.0%) | $77.66 M(+0.2%) |
| Mar 2018 | - | $26.14 M(-1317.1%) | $77.49 M(+9.1%) |
| Dec 2017 | $71.04 M(+2.8%) | -$2.15 M(-105.7%) | $71.04 M(+21.4%) |
| Sep 2017 | - | $37.45 M(+133.3%) | $58.53 M(-3.9%) |
| Jun 2017 | - | $16.05 M(-18.5%) | $60.87 M(-18.4%) |
| Mar 2017 | - | $19.69 M(-234.3%) | $74.63 M(+8.0%) |
| Dec 2016 | $69.08 M(-3.3%) | -$14.66 M(-136.8%) | $69.08 M(-28.3%) |
| Sep 2016 | - | $39.79 M(+33.5%) | $96.28 M(+36.1%) |
| Jun 2016 | - | $29.81 M(+110.9%) | $70.74 M(+19.3%) |
| Mar 2016 | - | $14.13 M(+12.7%) | $59.29 M(-17.0%) |
| Dec 2015 | $71.44 M(+59.6%) | $12.54 M(-12.0%) | $71.44 M(-0.8%) |
| Sep 2015 | - | $14.25 M(-22.4%) | $72.05 M(-12.6%) |
| Jun 2015 | - | $18.36 M(-30.2%) | $82.46 M(+15.9%) |
| Mar 2015 | - | $26.29 M(+99.9%) | $71.12 M(+58.9%) |
| Dec 2014 | $44.75 M(+308.0%) | $13.15 M(-46.7%) | $44.75 M(+15.6%) |
| Sep 2014 | - | $24.66 M(+251.2%) | $38.72 M(+22.4%) |
| Jun 2014 | - | $7.02 M(-8767.9%) | $31.62 M(+127.6%) |
| Mar 2014 | - | -$81.00 K(-101.1%) | $13.89 M(+26.7%) |
| Dec 2013 | $10.97 M(-210.4%) | $7.12 M(-59.5%) | $10.97 M(-145.3%) |
| Sep 2013 | - | $17.56 M(-264.1%) | -$24.23 M(-27.9%) |
| Jun 2013 | - | -$10.70 M(+256.0%) | -$33.59 M(-3.6%) |
| Mar 2013 | - | -$3.01 M(-89.3%) | -$34.84 M(+250.9%) |
| Dec 2012 | -$9.93 M(-115.1%) | -$28.07 M(-442.7%) | -$9.93 M(-125.0%) |
| Sep 2012 | - | $8.19 M(-168.5%) | $39.80 M(-7.8%) |
| Jun 2012 | - | -$11.95 M(-154.6%) | $43.16 M(-40.5%) |
| Mar 2012 | - | $21.91 M(+1.2%) | $72.48 M(+10.0%) |
| Dec 2011 | $65.90 M(-3.7%) | $21.65 M(+87.4%) | $65.90 M(+21.1%) |
| Sep 2011 | - | $11.55 M(-33.5%) | $54.44 M(-16.7%) |
| Jun 2011 | - | $17.37 M(+13.3%) | $65.33 M(+6.1%) |
| Mar 2011 | - | $15.33 M(+50.5%) | $61.57 M(-10.0%) |
| Dec 2010 | $68.43 M | $10.19 M(-54.6%) | $68.43 M(-27.2%) |
| Sep 2010 | - | $22.44 M(+64.9%) | $94.00 M(+2.3%) |
| Jun 2010 | - | $13.61 M(-38.7%) | $91.91 M(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $22.19 M(-37.9%) | $103.72 M(-10.3%) |
| Dec 2009 | $115.67 M(+95.4%) | $35.76 M(+75.7%) | $115.67 M(+12.4%) |
| Sep 2009 | - | $20.35 M(-19.9%) | $102.89 M(-3.4%) |
| Jun 2009 | - | $25.41 M(-25.6%) | $106.48 M(+40.4%) |
| Mar 2009 | - | $34.14 M(+48.5%) | $75.83 M(+28.1%) |
| Dec 2008 | $59.19 M(+142.0%) | $22.98 M(-4.0%) | $59.19 M(+30.2%) |
| Sep 2008 | - | $23.94 M(-557.4%) | $45.47 M(+74.7%) |
| Jun 2008 | - | -$5.23 M(-129.9%) | $26.03 M(-14.7%) |
| Mar 2008 | - | $17.50 M(+88.9%) | $30.52 M(+24.8%) |
| Dec 2007 | $24.45 M(-59.4%) | $9.27 M(+106.2%) | $24.45 M(-23.2%) |
| Sep 2007 | - | $4.49 M(-708.8%) | $31.84 M(-33.9%) |
| Jun 2007 | - | -$738.00 K(-106.5%) | $48.17 M(-22.8%) |
| Mar 2007 | - | $11.43 M(-31.3%) | $62.43 M(+3.7%) |
| Dec 2006 | $60.18 M(+23.3%) | $16.65 M(-20.0%) | $60.18 M(+5.4%) |
| Sep 2006 | - | $20.82 M(+54.0%) | $57.07 M(+21.8%) |
| Jun 2006 | - | $13.53 M(+47.3%) | $46.84 M(-1.4%) |
| Mar 2006 | - | $9.18 M(-32.2%) | $47.52 M(-2.6%) |
| Dec 2005 | $48.80 M(+60.2%) | $13.54 M(+27.9%) | $48.80 M(+23.7%) |
| Sep 2005 | - | $10.59 M(-25.5%) | $39.44 M(+0.9%) |
| Jun 2005 | - | $14.21 M(+36.0%) | $39.07 M(+18.6%) |
| Mar 2005 | - | $10.45 M(+150.0%) | $32.94 M(+8.1%) |
| Dec 2004 | $30.47 M(-1.7%) | $4.18 M(-59.1%) | $30.47 M(+7.0%) |
| Sep 2004 | - | $10.22 M(+26.4%) | $28.47 M(+12.1%) |
| Jun 2004 | - | $8.09 M(+1.4%) | $25.41 M(-17.2%) |
| Mar 2004 | - | $7.97 M(+264.5%) | $30.67 M(-1.0%) |
| Dec 2003 | $30.98 M(+4.2%) | $2.19 M(-69.4%) | $30.98 M(-21.9%) |
| Sep 2003 | - | $7.16 M(-46.4%) | $39.68 M(-1.2%) |
| Jun 2003 | - | $13.35 M(+61.2%) | $40.18 M(+21.4%) |
| Mar 2003 | - | $8.29 M(-23.9%) | $33.10 M(+11.3%) |
| Dec 2002 | $29.73 M(+131.5%) | $10.89 M(+42.4%) | $29.73 M(+20.8%) |
| Sep 2002 | - | $7.65 M(+21.8%) | $24.61 M(+10.8%) |
| Jun 2002 | - | $6.28 M(+27.9%) | $22.22 M(+63.4%) |
| Mar 2002 | - | $4.91 M(-14.9%) | $13.60 M(+5.9%) |
| Dec 2001 | $12.84 M(-256.1%) | $5.77 M(+9.8%) | $12.84 M(+155.7%) |
| Sep 2001 | - | $5.25 M(-324.7%) | $5.02 M(+455.5%) |
| Jun 2001 | - | -$2.34 M(-156.3%) | $904.00 K(-161.8%) |
| Mar 2001 | - | $4.15 M(-302.8%) | -$1.46 M(-82.2%) |
| Dec 2000 | -$8.23 M(-4363.2%) | -$2.05 M(-280.3%) | -$8.23 M(-187.4%) |
| Sep 2000 | - | $1.14 M(-124.1%) | $9.41 M(+50.0%) |
| Jun 2000 | - | -$4.71 M(+80.2%) | $6.28 M(-57.0%) |
| Mar 2000 | - | -$2.61 M(-116.7%) | $14.58 M(+7455.4%) |
| Dec 1999 | $193.00 K(-101.8%) | $15.59 M(-879.6%) | $193.00 K(-101.0%) |
| Sep 1999 | - | -$2.00 M(-155.6%) | -$18.68 M(-2.1%) |
| Jun 1999 | - | $3.60 M(-121.2%) | -$19.08 M(-25.4%) |
| Mar 1999 | - | -$17.00 M(+418.3%) | -$25.58 M(+133.0%) |
| Dec 1998 | -$10.98 M(+26.2%) | -$3.28 M(+36.7%) | -$10.98 M(-9.3%) |
| Sep 1998 | - | -$2.40 M(-17.2%) | -$12.10 M(+5.2%) |
| Jun 1998 | - | -$2.90 M(+20.8%) | -$11.50 M(+16.2%) |
| Mar 1998 | - | -$2.40 M(-45.5%) | -$9.90 M(+13.8%) |
| Dec 1997 | -$8.70 M(-5.4%) | -$4.40 M(+144.4%) | -$8.70 M(-478.3%) |
| Sep 1997 | - | -$1.80 M(+38.5%) | $2.30 M(-135.4%) |
| Jun 1997 | - | -$1.30 M(+8.3%) | -$6.50 M(-18.8%) |
| Mar 1997 | - | -$1.20 M(-118.2%) | -$8.00 M(-13.0%) |
| Dec 1996 | -$9.20 M(+8.2%) | $6.60 M(-162.3%) | -$9.20 M(-41.8%) |
| Sep 1996 | - | -$10.60 M(+278.6%) | -$15.80 M(+203.8%) |
| Jun 1996 | - | -$2.80 M(+16.7%) | -$5.20 M(+116.7%) |
| Mar 1996 | - | -$2.40 M | -$2.40 M |
| Dec 1995 | -$8.50 M | - | - |
FAQ
- What is Integra LifeSciences Holdings annual free cash flow?
- What is the all time high annual FCF for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual FCF year-on-year change?
- What is Integra LifeSciences Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly FCF year-on-year change?
- What is Integra LifeSciences Holdings TTM free cash flow?
- What is the all time high TTM FCF for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings TTM FCF year-on-year change?
What is Integra LifeSciences Holdings annual free cash flow?
The current annual FCF of IART is $73.09 M
What is the all time high annual FCF for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual free cash flow is $264.35 M
What is Integra LifeSciences Holdings annual FCF year-on-year change?
Over the past year, IART annual free cash flow has changed by -$144.29 M (-66.38%)
What is Integra LifeSciences Holdings quarterly free cash flow?
The current quarterly FCF of IART is -$7.16 M
What is the all time high quarterly FCF for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly free cash flow is $84.66 M
What is Integra LifeSciences Holdings quarterly FCF year-on-year change?
Over the past year, IART quarterly free cash flow has changed by -$20.85 M (-152.30%)
What is Integra LifeSciences Holdings TTM free cash flow?
The current TTM FCF of IART is $38.04 M
What is the all time high TTM FCF for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high TTM free cash flow is $274.39 M
What is Integra LifeSciences Holdings TTM FCF year-on-year change?
Over the past year, IART TTM free cash flow has changed by -$71.71 M (-65.34%)